Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Immune Network Ltd.
DescriptionOral therapeutic vaccine comprising heat-inactivated Mycobacterium
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsTreat pulmonary tuberculosis (TB) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today